![]() ME/CFS South Australia Inc supports the needs of sufferers of Myalgic Encephalomyelitis, Chronic Fatigue Syndrome and related illnesses. We do this by providing services and information to members. Disclaimer ME/CFS South Australia Inc aims to keep members informed of various research projects, diets, medications, therapies, news items, etc. All communication, both verbal and written, is merely to disseminate information and not to make recommendations or directives. Unless otherwise stated, the views expressed on this Web site are not necessarily the official views of the Society or its Committee and are not simply an endorsement of products or services. |
|
|||||||||||
Study Finds Cannabis May Be Suitable Treatment Option For FibromyalgiaSaturday 29 June 2019
Study Finds Cannabis May Be Suitable Treatment Option for Fibromyalgia Researchers in Israel found that medical cannabis therapy helped reduce pain and improve quality of life for most fibromyalgia patients. Somewhere between three and six million people in the United States suffer from fibromyalgia, a chronic pain syndrome that doctors scarcely understand and struggle to effectively treat. But for years, many fibromyalgia patients have shared their stories and experiences treating their symptoms with cannabis. Yet while patients frequently self-report using cannabis to manage their fibromyalgia, there are only a few clinical studies that have assessed whether cannabis can be an effective treatment for the disease. The studies that do exist, however, all present positive results. And a new investigation into the characteristics, safety and effectiveness of medical cannabis therapy for fibromyalgia just added more evidence to the pile. According to the authors of that study, a team of medical researchers in Israel, cannabis may be a suitable treatment option for fibromyalgia. Marijuana Helped Reduce Pain for 81 Percent of Fibromyalgia Patients “Safety and Efficacy of Medical Cannabis in Fibromyalgia,” a study published this month in the Journal of Clinical Medicine, assessed 367 fibromyalgia patients’ use of cannabis over a six-month period. Of those patients, 301 were women, and at the end of the six-month assessment period, 261 patients participated in a survey. (Some patients stopped their medical cannabis treatments.) That survey aimed to gather data about how well cannabis managed pain symptoms associated with fibromyalgia. It also asked patients about any side effects associated with their medical cannabis treatments. The results reveal just how effective cannabis can be as a treatment option for fibromyalgia. According to the study, patients began the six-month trial with a baseline pain intensity of 9.0 on a scale of zero to 10. At the end of the six-month assessment period, median pain intensity reduced to 5.0. Furthermore, 194 patients (81.1 percent) experienced at least some improvement in their condition without any serious side effects.
blog comments powered by Disqus |
||||||||||||
|
Registered Charity 3104
Email:
sacfs@sacfs.asn.au
Mailing address:
PO Box 322,
Modbury North,
South Australia 5092
Phone:
1300 128 339
Office Hours:
Monday - Friday,
10am - 4pm
(phone)